Because pancreatic cancer is such a rapidly fatal malignancy and most patients die of the cancer, the comorbidity associated with obesity, such as cardiovascular disease, could not explain the reduced overall survival rate.Insulin resistance may serve as a common mechanism for the observed associations between obesity and increased risk, earlier onset, and reduced survival in patients with pancrea